Ion Beam Applications SA (id:373 IBAB)
13.28 EUR
Opening hours: 09:00 - 17:30 (Central European Standard Time: 11/21/2024 3:19:17 PM)
Exchange open, closes in 2 hours 10 minutes
About Ion Beam Applications SA
Market Capitalization 389.40M
Ion Beam Applications SA develops, manufactures, and supports medical devices and software solutions for cancer treatments in Belgium, the United States, and internationally. The company operates through Proton Therapy and Other Accelerators, and Dosimetry segments. The Proton Therapy and Other Accelerators segment develops, fabricates, and services medical and industrial particle accelerators, and proton therapy systems. This segment also offers turnkey solutions for the treatment of cancer through the use of proton beams; and a line of cyclotrons used for the production of positron emission tomography or SPECT radioisotopes, as well as a line of industrial accelerators for sterilization and ionization. The Dosimetry segment provides solutions and services that enhances efficiency and minimizes errors in radiation therapy and medical imaging quality assurance and calibration procedures. The company has strategic research and development partnership with SCK CEN (Belgian nuclear research center) to enable the production of Actinimum-225 (225Ac), a novel radioisotope for the treatment of cancer; and an agreement with University of Pennsylvania for research in ConformalFLASH. It also has a research partnership with Particle Therapy Interuniversity Center Leuven for the development of ConformalFLASH1. Ion Beam Applications SA was incorporated in 1986 and is headquartered in Louvain-la-Neuve, Belgium.
| Headquarters (address) |
3, Chemin du Cyclotron Louvain-la-Neuve 1348 Belgium |
| Phone | 32 1 047 58 11 |
| Website | https://www.iba-worldwide.com |
| Employees | 1,943 |
| Sector | Healthcare |
| Industry | Medical Devices |
| Ticker | IBAB |
| Exchange | European Stock Exchange |
| Currency | EUR |
| 52 week range | 9.31 - 15.14 |
| Market Capitalization | 389.40M |
| Dividend yield forward | 5.14 % |
| Dividend yield forward Belgium (ID:14, base:73) | 18.02 % |
| P/E trailing | 48.22 |
| P/E forward | 13.02 |
| Price/Sale | 0.836 |
| Price/Book | 4.21 |
| Beta | 0.986 |
| EPS | 0.270 |
| EPS Belgium (ID:14, base:79) | 4.64 |
Dividend growth streak
Ion Beam Applications SA has raised their dividend 1.00 years in a row. This is below the 4.478497 year average in the 'Medical Devices' industry
Forward Annual Dividend Yield
Forward Annual Dividend Yield: Ion Beam Applications SA has raised their dividend 5.14 years in a row. This is below the 41793.889600 year average in the 'Medical Devices' industry
Compound Average Growth Rate 3 Years
Compound Average Growth Rate 3 Years: Ion Beam Applications SA has raised their dividend 40.32 years in a row. This is above the 24.014500 year average in the 'Medical Devices' industry
Payout Ratio
Payout Ratio: Ion Beam Applications SA has raised their dividend 62.82 years in a row. This is below the 146.967900 year average in the 'Medical Devices' industry
Dividend growth streak
Ion Beam Applications SA has raised their dividend 1.00 years in a row. This is below the 4.478497 year average in the 'Medical Devices' industry
Forward Annual Dividend Yield
Forward Annual Dividend Yield: Ion Beam Applications SA has raised their dividend 5.14 years in a row. This is below the 41793.889600 year average in the 'Medical Devices' industry
Compound Average Growth Rate 3 Years
Compound Average Growth Rate 3 Years: Ion Beam Applications SA has raised their dividend 40.32 years in a row. This is above the 24.014500 year average in the 'Medical Devices' industry
Payout Ratio
Payout Ratio: Ion Beam Applications SA has raised their dividend 62.82 years in a row. This is below the 146.967900 year average in the 'Medical Devices' industry